Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fred Reu"'
Autor:
Matt Kalaycio, Navneet S. Majhail, Brian J. Bolwell, Robert M. Dean, Ronald Sobecks, Hien Liu, Donna Corrigan, Betty K. Hamilton, Brian T. Hill, Fred Reu, Brad Pohlman, Aaron T. Gerds, Deepa Jagadeesh, Jack Khouri
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:S335
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e7d0486c75547071a04fbb3b38ea2a3
https://doi.org/10.1016/j.bbmt.2017.12.395
https://doi.org/10.1016/j.bbmt.2017.12.395
Autor:
Brian J. Bolwell, Hien K. Duong, Jason Valent, Christy J. Samaras, Ronald Sobecks, Rabi Hanna, Navneet S. Majhail, Donna Abounader, Steven Andresen, Fred Reu, Lisa Rybicki, Brad Pohlman, Aaron T. Gerds, Deepa Jagadeesh, Betty K. Hamilton, Matt Kalaycio
Publikováno v:
Biology of Blood and Marrow Transplantation. 21(2):S133-S134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1466c12e50af4046e3222b6c337dfff4
Autor:
Keith Stockerl-Goldstein, Richy Agajanian, Max Qian, Weiyuan Chung, Nizar J. Bahlis, Fred Reu, Jorge Mouro, Ehsan Malek, Syed Rizvi, Anjan Thakurta, David S. Siegel, Gary J. Schiller, Hakan Kaya, Kevin W. Song, Michael Sebag, Shankar Srinivasan
Publikováno v:
Blood. 128:4497-4497
Background: Pomalidomide (POM) in combination with low-dose dexamethasone (LoDEX) is approved for the treatment (Tx) of patients (pts) with multiple myeloma (MM) who have had ≥ 2 prior lines of therapy, including lenalidomide (LEN) and a proteasome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d03c5f83977c9d971f3f07ac1ef845ac
https://doi.org/10.1182/blood.v128.22.4497.4497
https://doi.org/10.1182/blood.v128.22.4497.4497